Moderna (MRNA) News Today $32.66 +0.21 (+0.65%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$32.74 +0.08 (+0.26%) As of 03/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Northwest & Ethical Investments L.P.Northwest & Ethical Investments L.P. grew its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 209.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 43,466 shares of the company's stoMarch 23 at 5:14 AM | marketbeat.comRaymond James Financial Inc. Acquires Shares of 204,249 Moderna, Inc. (NASDAQ:MRNA)Raymond James Financial Inc. acquired a new stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 204,249 shares of the company's stock, valued at approximately $8,493,000. Raymond James FMarch 23 at 3:11 AM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of "Hold" from AnalystsModerna, Inc. (NASDAQ:MRNA - Get Free Report) has been given a consensus recommendation of "Hold" by the twenty-four ratings firms that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a sell rating, sixteen have issued a hold rating, tMarch 23 at 2:51 AM | marketbeat.comModerna (NASDAQ:MRNA) Price Target Lowered to $33.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. lowered their target price on Moderna from $40.00 to $33.00 and set an "underweight" rating on the stock in a research report on Friday.March 22 at 12:43 PM | marketbeat.comBuying These Dirt-Cheap Stocks Could Be a Brilliant MoveMarch 22 at 6:44 AM | fool.comModerna price target lowered to $33 from $40 at JPMorganMarch 21 at 6:39 PM | markets.businessinsider.comCrucial mRNA vaccine research at risk in the USMarch 21 at 1:35 PM | msn.com2MRNA : Moderna's Options: A Look at What the Big Money is ThinkingMarch 20 at 10:41 PM | benzinga.comVaccine makers face mRNA backlash as states seek further restrictionsMarch 20 at 9:18 AM | finance.yahoo.com4 Things You Need to Know if You Buy Moderna Stock TodayMarch 20 at 9:05 AM | fool.comModerna, Inc. (NASDAQ:MRNA) Shares Acquired by Privium Fund Management B.V.Privium Fund Management B.V. lifted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 103.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 82,476 shares of the company's stock after buyingMarch 20 at 6:18 AM | marketbeat.com2 No-Brainer Biotech Stocks to Buy Right NowMarch 19, 2025 | fool.commRNA Vaccines Market Trends and Competition Analysis 2025-2030: Revenues are Projected to Nearly Double, Growing by ~$8 BillionMarch 18, 2025 | globenewswire.comWealthfront Advisers LLC Lowers Position in Moderna, Inc. (NASDAQ:MRNA)Wealthfront Advisers LLC lowered its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 84.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,013 shares of the company's sMarch 18, 2025 | marketbeat.comScientists say NIH officials told them to scrub mRNA references on grantsMarch 17, 2025 | msn.com10,100 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Intact Investment Management Inc.Intact Investment Management Inc. acquired a new position in Moderna, Inc. (NASDAQ:MRNA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 10,100 shares of the company's stock, valuedMarch 17, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Cuts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)Skandinaviska Enskilda Banken AB publ trimmed its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 16.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 66,455 shares of the company's stock after sellMarch 17, 2025 | marketbeat.comSwiss National Bank Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)Swiss National Bank lowered its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 4.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 923,000 shares of the company's stock after selling 43,800 shares during the quarter. Swiss National BaMarch 17, 2025 | marketbeat.comProficio Capital Partners LLC Buys 144,099 Shares of Moderna, Inc. (NASDAQ:MRNA)Proficio Capital Partners LLC grew its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 4,418.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 147,360 shares of the company's stock after acquiring an additionaMarch 17, 2025 | marketbeat.comCatalyst Funds Management Pty Ltd Buys Shares of 35,200 Moderna, Inc. (NASDAQ:MRNA)Catalyst Funds Management Pty Ltd bought a new stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 35,200 shares of the company's stock, valued aMarch 16, 2025 | marketbeat.comLbp Am Sa Has $7.68 Million Stake in Moderna, Inc. (NASDAQ:MRNA)Lbp Am Sa boosted its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 4,643.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 184,606 shares of the company's stock after buying an additional 180,714 shares dMarch 16, 2025 | marketbeat.comModerna (NASDAQ:MRNA) Earns Neutral Rating from Analysts at CitigroupMarch 16, 2025 | americanbankingnews.comModerna, Inc. (NASDAQ:MRNA) Position Cut by Victory Capital Management Inc.Victory Capital Management Inc. reduced its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 59.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 115,932 shares of the company's stock after sellingMarch 16, 2025 | marketbeat.comMarketBeat Week in Review – 03/10 - 03/14 (MRNA)Stocks continued to be under pressure on concerns over tariffs and growing inflation concerns, but history shows that corrections can set up opportunitiesMarch 15, 2025 | marketbeat.comDown 93%, Is It Finally Time to Buy Moderna?March 15, 2025 | fool.comDaiwa Securities Group Inc. Sells 18,926 Shares of Moderna, Inc. (NASDAQ:MRNA)Daiwa Securities Group Inc. lowered its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 27.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 51,265 shares of the company's stock after selling 18,926 sharMarch 15, 2025 | marketbeat.comShort bets against S&P 500 healthcare stock rises in Feb; MRNA stays top shortedMarch 15, 2025 | msn.comHead-To-Head Comparison: Moderna (NASDAQ:MRNA) and BioCardia (NASDAQ:BCDA)March 15, 2025 | americanbankingnews.comCitigroup Initiates Coverage on Moderna (NASDAQ:MRNA)Citigroup initiated coverage on shares of Moderna in a research note on Thursday. They set a "neutral" rating and a $40.00 price objective on the stock.March 14, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Buys 168,975 Shares of Moderna, Inc. (NASDAQ:MRNA)Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 107.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 326,749 shares of the company's stock after acquiring an addiMarch 13, 2025 | marketbeat.comAmundi Purchases 535,273 Shares of Moderna, Inc. (NASDAQ:MRNA)Amundi lifted its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 79.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,206,273 shares of the company's stock after purchasing an additional 535,273 sMarch 13, 2025 | marketbeat.comModerna (NASDAQ:MRNA) Trading Down 6.3% - What's Next?Moderna (NASDAQ:MRNA) Shares Down 6.3% - Here's What HappenedMarch 12, 2025 | marketbeat.com3 Reasons MRNA is Risky and 1 Stock to Buy InsteadMarch 12, 2025 | msn.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Edgestream Partners L.P.Edgestream Partners L.P. cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 42.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 26,417 shares of the company's stoMarch 12, 2025 | marketbeat.comTrump is running from his biggest health care successMarch 11, 2025 | msn.comModerna (MRNA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)March 11, 2025 | seekingalpha.comInsiders Are Loading Up on These 4 Biotech Stocks NowMarch 11, 2025 | 247wallst.comModerna: 4 Key Reasons the CEO Just Bought $5M in SharesModerna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.March 11, 2025 | marketbeat.comModerna suffers setback in vaccine patent battle with PfizerMarch 10, 2025 | bizjournals.comBioNTech Surpasses Q4 Revenue EstimatesMarch 10, 2025 | fool.comMRNA Vaccines, Once a Trump Boast, Now Face Attacks From Some in GOPMarch 10, 2025 | msn.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Bank Julius Baer & Co. Ltd ZurichBank Julius Baer & Co. Ltd Zurich lowered its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 46.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 98,269 shares of the company's stocMarch 10, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Holdings Cut by Vestmark Advisory Solutions Inc.Vestmark Advisory Solutions Inc. lowered its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 55.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,029 shares of the company's stock after selling 8,643 sMarch 10, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $97.47 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Charles Schwab Investment Management Inc. increased its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 9.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,344,203 shares of the company's stock after purchasing an additional 211,426 sharesMarch 10, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Acquired by Jones Financial Companies LllpJones Financial Companies Lllp grew its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 113.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,841 shares of the company's stock after buyinMarch 10, 2025 | marketbeat.com35,203 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by AMF Tjanstepension ABAMF Tjanstepension AB acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 35,203 shares of the company's sMarch 9, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Stock Holdings Lifted by Banco Santander S.A.Banco Santander S.A. grew its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 99.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 105,811 shares of the company's stock after acquiring an additional 52,696 shares during the period. Banco SantMarch 9, 2025 | marketbeat.comMRNA vaccines now face attacks from some in the GOPMarch 8, 2025 | msn.comModerna (NASDAQ:MRNA) Stock Price Up 7.7% - Here's What HappenedModerna (NASDAQ:MRNA) Stock Price Up 7.7% - Time to Buy?March 8, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Bought by E Fund Management Co. Ltd.E Fund Management Co. Ltd. raised its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 35.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 30,592 shares of the company's stock after purchasingMarch 8, 2025 | marketbeat.com Remove Ads Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.580.64▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼2024▲MRNA Articles Average Week Remove Ads Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Intra-Cellular Therapies News Genmab A/S News Viatris News Dr. Reddy's Laboratories News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 3/23/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRNA Stock Free MRNA Stock Alerts